Search

You searched for "radiation"

1059 results found

Trials offering cytoreductive surgery for men with de novo synchronous metastatic prostate cancer

8 November 2021 | | URO - Basic Science Research, URO - Urologic Oncology
Life expectancy in men diagnosed with de novo synchronous metastatic hormone-sensitive prostate cancer (mHSPC) has risen to a median of 4.8 years with upfront systemic agents (such as docetaxel) in addition to standard androgen deprivation therapy (ADT) [1-3]. Within this...
Neurourology and Urodynamics journal cover image.

Pacemakers in the upper urinary tract

1 March 2014 | | URO - Basic Science Research, URO - Functional / Reconstructive Urology
This is an interesting study from Italy. The mechanism by which urine is transported from the kidney to the bladder via the upper urinary tract (UUT) remains poorly understood and elusive. For many years, pyeloureteric rhythmicity is thought to arise...
International Urogynecology Journal cover image.

Mindfulness-based stress reduction as a novel treatment for IC/PBS

1 July 2017 | | URO - Functional / Reconstructive Urology
Interstitial cystitis / painful bladder syndrome (IC / PBS) is not fully understood and is associated with significant morbidity. The objective of this study was to provide initial data to evaluate mindfulness-based stress reduction (MBSR) as a treatment for IC...

Metastatic spinal cord compression – a review

1 March 2014 | | URO - Trauma & Emergency, URO - Urologic Oncology
Introduction Metastatic spinal cord compression (MSCC) is an oncological emergency that, unless diagnosed early and treated appropriately, can lead to significant morbidity and mortality, including paralysis and bladder and bowel dysfunction. MSCC can be defined as spinal cord or cauda...

Imaging and surveillance in sporadic renal angiomyolipoma: how and when to monitor effectively

4 March 2025 | | URO - Urologic Oncology
Renal angiomyolipoma (AML) are benign tumours, accounting for approximately 2–3% of all renal neoplasms [1]. Seventy percent of renal AMLs are sporadic, and 20–30% are associated with genetic aetiology. They are composed of smooth muscle, blood vessels, and adipose tissue....

What is the role of evidence-based medicine in urology?

1 March 2016 | | URO - Basic Science Research
The concept of ‘evidence-based medicine’ (EBM) was first developed in the early 1990s and was described as “the conscientious, explicit and judicious use of the current best evidence in making decisions about the care of individual patients” by the recently...

Lasers in benign prostatic hyperplasia

1 January 2014 | | URO - Functional / Reconstructive Urology, URO - Technology
Clinical benign prostatic hyperplasia (BPH) impacts on the quality of life of many men. It is intimately related to ageing, but exact calculations of its prevalence remain difficult since an accurate clinical definition still eludes us. Histological BPH has been...

Prostate cancer

1 July 2015 | | URO - Urologic Oncology
Case 1 What is prostate specific antigen (PSA) and what is its function? According to the ERSPC Trial (at 13 years), what was the number needed to screen and diagnosed to prevent one prostate cancer death and what was the...

Innovations in flexible ureteroscopy for renal calculi: a comprehensive review

7 January 2026 | | URO - Endourology & Stones, URO - Technology
This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Flexible ureteroscopy (f-URS) has become a core modality in the treatment of...

An algorithm for the management of haemorrhagic cystitis

1 September 2015 | | URO - Endourology & Stones, URO - Functional / Reconstructive Urology, URO - Urologic Oncology
Haemorrhagic cystitis (HC) can be one of the most difficult conditions to treat in urological practice. It is characterised by intractable bleeding from the bladder and may be acute or chronic. The most frequently reported causal factors are radiotherapy (RT)...

26th Asia-Pacific Prostate Cancer Conference (APCC2026)

13 August 2026 -15 August 2026
Prostate cancer continues to represent a major global health challenge, profoundly impacting the lives of men and their families every day. Yet, over the past decade, transformative advances have changed the landscape of prostate cancer management enabling men to live...

Can we make LATE-presenting posterior urethral valves an EARLIER-treated condition?

3 September 2024 | | URO - Paediatrics
What are posterior urethral valves? Posterior urethral valve (PUV) is the most common cause of congenital bladder outlet obstruction (BOO) and renal failure in male children. They were first described by the Italian anatomist Giovanni Battista Morgagni back in the...